Milestones

•2016 Q1 Completed A round of financing
•2017 Q3 Initiated XG005 capsule FIH (XG005-01) trial in Australia
•2018 Q1 Completed XG005-01 trial
•2018 Q4 Completed B round of financing
•2019 Q2 Completed B+ round of financing
•2019 Q3 Initiated XG005 tablet SAD/MAD (XG005-02) trial in Australia
•2019 Q4 Initiated XG005 topical SAD/MAD (XG005-03) trial in Australia